This Biotech Stock Is Flying High After Rival Heart Drugs StumbledInvestors Business Daily • 01/13/20
Amarin Launches True To Your Heart, a Campaign to Educate People on Persistent Cardiovascular RiskGlobeNewsWire • 01/13/20
Amarin raises 2019 revenue outlook, to double sales team as it 'aggressively' launches Vascepa in the U.S.Market Watch • 01/07/20
Amarin Provides Update to Preliminary 2019 Results and Further Details on 2020 OutlookGlobeNewsWire • 01/07/20
Matinas And Amarin, And Other News And Issues: The Good, Bad, And Ugly Of BiopharmaSeeking Alpha • 01/06/20